Keytruda

Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
Yahoo/Reuters
Thu, 08/25/16 - 09:25 pm
lung cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
TheStreet.com
Tue, 08/23/16 - 05:44 pm
Keytruda
Merck
Recent FDA Approvals - Aug 15 2016
CP Wire
Mon, 08/15/16 - 03:50 pm
Aurobindo
Merck
FDA
drug approvals
Sun Pharma
Santarus
Keytruda
Boston Scientific
devices
Heron Therapeutics
Why Merck’s Lung Cancer Success Won’t Last
Barron's
Tue, 08/9/16 - 10:39 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Opdivo bet backfires, creates opening for Merck to pursue DTC
Medical Marketing and Media
Mon, 08/8/16 - 11:18 am
Opdivo
Merck
Bristol-Myers Squibb
Keytruda
DTC advertising
Merck’s KEYTRUDA® (pembrolizumab) Approved by the European Commission for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
Yahoo
Wed, 08/3/16 - 09:02 am
Merck
Keytruda
Europe
non-small cell lung cancer
Bristol-Myers takes a commanding lead over Merck in the first stretch of a blockbuster race
Endpoints
Fri, 07/29/16 - 08:44 pm
Bristol-Myers Squibb
Merck
Keytruda
Opdivo
PDL-1 inhibitors
Can Keytruda Deliver Earnings Growth For Merck?
Yahoo/Benzinga
Wed, 07/27/16 - 03:07 pm
Merck
Keytruda
earnings
Will Merck & Co Keytruda Surpass Bristol-Myers Opdivo In Immunotherapies Race?
Bidness, ETC
Fri, 06/17/16 - 10:17 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
cancer immunotherapy
Merck Extends Cancer Immunotherapy Reach to First-Line Lung Cancer
TheStreet.com
Thu, 06/16/16 - 09:57 am
Merck
Keytruda
non-small cell lung cancer
New Data for KEYTRUDA® (pembrolizumab) in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at 2016 ASCO Annual Meeting
Yahoo
Sun, 06/5/16 - 11:57 am
Keytruda
Merck
ASCO 2016
melanoma
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Pfizer cancer drug shows promise in combo with Merck's Keytruda
Yahoo/Reuters
Thu, 05/19/16 - 09:39 am
Pfizer
Merck
Keytruda
utomilumab
cancer immunotherapy
clinical trials
Keytruda: The Rising Hope of Merck & Co.
Yahoo/Market Realist
Mon, 05/9/16 - 09:51 pm
Merck
Keytruda
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review
Yahoo/Benzinga
Wed, 04/13/16 - 09:55 am
Merck
FDA
Keytruda
metastatic head and neck squamous cell carcinoma
Cholesterol pill boosts cancer immunotherapy, at least in mice
Yahoo/Reuters
Thu, 03/17/16 - 05:03 pm
Opdivo
Keytruda
Avasimibe
Merck
Bristol-Myers Squibb
cancer immunotherapy
Pfizer
Merck's Keytruda held back by docs who don't want to wait for diagnostics
Fierce Pharma Marketing
Mon, 03/14/16 - 05:59 pm
Merck
Keytruda
physicians
Opdivo
Bristol-Myers Squibb
FDA accepts new Keytruda data, opening door for wider indication
BioPharma Dive
Wed, 03/9/16 - 03:38 pm
FDA
Keytruda
Merck
metastatic non-small cell lung cancer

Pages